GlassScriptPhysician profile
Zhengyu Hu
NPI 1366498867
$3,547.83
in general payments reported to CMS, 2019-2025
30 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $474 · 2021: $756 · 2022: $297 · 2023: $375 · 2024: $346 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082 · Travel and Lodging: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.15 |
| Travel and Lodging | $155.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $787.59 | 2019-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $467.68 | 2019-2025 | Ztlido |
| Biodelivery Sciences International, INC. | $400.69 | 2019-2021 | |
| Pfizer INC. | $280.34 | 2019-2024 | |
| Abbott Laboratories | $238.11 | 2019-2021 | |
| Abbvie INC. | $193.68 | 2021-2023 | |
| Amgen INC. | $187.93 | 2019-2021 | |
| Curonix LLC | $176.52 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ibsa Pharma INC. | $120.79 | 2021-2025 | Tirosint, Licart, Tirosint |
| Horizon Therapeutics Plc | $114.02 | 2021-2022 | |
| Protega Pharmaceutials INC | $96.44 | 2025 | Roxybond |
| Zyla Life Sciences, INC. | $68.04 | 2019 | |
| Virtus Pharmaceuticals LLC | $37.92 | 2020-2021 | |
| Sanofi Pasteur INC. | $37.16 | 2021-2022 | |
| Sentynl Therapeutics, INC. | $34.30 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $34.19 | 2019 | |
| Nalu Medical, INC. | $31.36 | 2020 | |
| Merit Medical Systems INC | $23.18 | 2022 | |
| Biotissue Holdings INC. | $23.03 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $22.18 | 2023 | Iovera, Zilretta |
| Grt US Holding, INC. | $20.46 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $19.87 | 2022 | |
| International Rehabilitative Sciences, INC | $19.66 | 2023 | Rs 4i Plus Sequential Stimulator |
| Nevro Corp. | $19.51 | 2019 | |
| Spr Therapeutics, INC | $18.41 | 2023 | Sprint Pns System |
| Mdd US Operations, LLC | $16.95 | 2019 | |
| Assertio Therapeutics, INC. | $16.51 | 2020 | |
| Lundbeck LLC | $15.62 | 2021 | |
| Zimmer Biomet Holdings, INC. | $12.92 | 2019 | |
| Metacel Pharmaceuticals LLC | $12.77 | 2023 | Ozobax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhengyu Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.